Scott Bizily insider trades: 4D Molecular Therapeutics (FDMT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Scott reports to the SEC
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | FDMT | ↓ Sell | 1,635 | $12.84 | $21K | Direct | Oct 20, 2026 (4d) |
| Sep 16, 2026 | FDMT | ↓ Sell | 1,635 | $13.65 | $22K | Direct | Sep 22, 2026 (6d) |
| Sep 1, 2026 | FDMT | ↓ Sell | 584 | $14.00 | $8K | Direct | Sep 3, 2026 (2d) |
| Aug 17, 2026 | FDMT | ↓ Sell | 3,270 | $12.10 | $40K | Direct | Aug 17, 2026 (0d) |
| Dec 16, 2025 | FDMT | ↓ Sell | 1,635 | $10.90 | $18K | Direct | Dec 19, 2025 (3d) |
| Nov 17, 2025 | FDMT | ↓ Sell | 1,635 | $10.59 | $17K | Direct | Nov 19, 2025 (2d) |
| Oct 24, 2025 | FDMT | ↓ Sell | 2,678 | $12.00 | $32K | Direct | Oct 27, 2025 (3d) |
| Oct 16, 2025 | FDMT | ↓ Sell | 1,635 | $10.17 | $17K | Direct | Oct 20, 2025 (4d) |
| Oct 9, 2025 | FDMT | ↓ Sell | 2,408 | $10.00 | $24K | Direct | Oct 14, 2025 (5d) |
| Sep 23, 2025 | FDMT | ↓ Sell | 2,407 | $8.00 | $19K | Direct | Sep 26, 2025 (3d) |
| Sep 16, 2024 | FDMT | ↓ Sell | 500 | $16.33 | $8K | Direct | Sep 18, 2024 (2d) |
| Aug 19, 2024 | FDMT | ↓ Sell | 500 | $15.00 | $8K | Direct | Aug 21, 2024 (2d) |
| Jul 16, 2024 | FDMT | ↓ Sell | 1,750 | $27.11 | $47K | Direct | Jul 18, 2024 (2d) |
| Jul 11, 2024 | FDMT | ↓ Sell | 1,996 | $25.00 | $50K | Direct | Jul 15, 2024 (4d) |
| Jul 1, 2024 | FDMT | ↓ Sell | 4,248 | $21.36 | $91K | Direct | Jul 3, 2024 (2d) |
| Jun 17, 2024 | FDMT | ↓ Sell | 1,750 | $23.71 | $41K | Direct | Jun 20, 2024 (3d) |
| May 16, 2024 | FDMT | ↓ Sell | 1,750 | $25.45 | $45K | Direct | May 20, 2024 (4d) |
| Apr 16, 2024 | FDMT | ↓ Sell | 1,750 | $25.74 | $45K | Direct | Apr 18, 2024 (2d) |
| Apr 1, 2024 | FDMT | ↓ Sell | 8,153 | $31.78 | $259K | Direct | Apr 3, 2024 (2d) |
| Mar 27, 2024 | FDMT | ↓ Sell | 5,833 | $35.04 | $204K | Direct | Mar 29, 2024 (2d) |
| Mar 18, 2024 | FDMT | ↓ Sell | 1,750 | $31.27 | $55K | Direct | Mar 20, 2024 (2d) |
| Feb 27, 2024 | FDMT | ↓ Sell | 1,909 | $30.00 | $57K | Direct | Feb 29, 2024 (2d) |
| Feb 16, 2024 | FDMT | ↓ Sell | 1,750 | $27.67 | $48K | Direct | Feb 21, 2024 (5d) |
| Feb 8, 2024 | FDMT | ↓ Sell | 6,244 | $27.50 | $172K | Direct | Feb 12, 2024 (4d) |
| Jun 8, 2023 | FMDT | ↓ Sell | 3,750 | $20.85 | $78K | Direct | Jun 12, 2023 (4d) |
| Jun 1, 2023 | FMDT | ↓ Sell | 2,247 | $18.31 | $41K | Direct | Jun 6, 2023 (5d) |
| Apr 21, 2023 | FDMT | ↓ Sell | 3,750 | $20.00 | $75K | Direct | Apr 25, 2023 (4d) |
| Mar 1, 2023 | FDMT | ↓ Sell | 2,248 | $19.30 | $43K | Direct | Mar 3, 2023 (2d) |
| Dec 1, 2022 | FDMT | ↓ Sell | 5,900 | $22.76 | $134K | Direct | Dec 5, 2022 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FDMT insiders
Open-market trades in the last 12 months
About Scott Bizily's insider trades
Scott Bizily is Chief Legal Officer at 4D Molecular Therapeutics (FDMT). Since Dec 1, 2022, Scott has reported no open-market purchases and 29 sales worth $1.7M on SEC Form 4. In the last 12 months: 6 sales ($126K).
Their filings also include option exercises (27 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FDMT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.